Previous Close | 655.01 |
Open | 661.87 |
Bid | 660.00 x 800 |
Ask | 675.00 x 800 |
Day's Range | 652.03 - 670.96 |
52 Week Range | 492.13 - 747.42 |
Volume | |
Avg. Volume | 655,730 |
Market Cap | 71.791B |
Beta (5Y Monthly) | 0.21 |
PE Ratio (TTM) | 10.68 |
EPS (TTM) | 62.53 |
Earnings Date | Feb 03, 2022 - Feb 07, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 702.05 |
Regeneron, Vertex, Intercept Pharmaceuticals, and Biohaven Pharmaceutical are part of Zacks top Analyst Blog
Earnings and regulatory updates from Regeneron (REGN) and Vertex (VRTX) are a few key highlights from the biotech sector during the past week.
It is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent performance, when its stock...